Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

NAAA protein levels

SCARB2 · rs144228170

Strength of the evidence

3 / 4

Its strongest genetic-study result is p = 10−63, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 47,745 European ancestry individuals.

The effect Each copy of the C allele shifted the measure 0.315 lower (95% confidence interval 0.27-0.36); p = 5 × 10−64.

How common The C allele had a frequency of about 1% in the people studied.

Where it sits Chromosome 4, band 4q21.1 — in an intron of SCARB2.

What ClinVar records

Classification Likely benign; criteria provided, single submitter (1 of 4 stars, 1 submitter), last evaluated 2018-06-19. ClinVar record 671753 NM_005506.4(SCARB2):c.994+280A>G

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-16 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

CT
Korean KRGDB
C 0.1% · T 99.9%
Japanese ToMMo
T 100.0%
World gnomAD
C 1.2% · T 98.8%
World 1000 Genomes
C 0.6% · T 99.4%
World TOPMed
C 1.1% · T 98.9%

By ancestry gnomAD

European (non-Finnish)
C 1.7% · T 98.3%
African / African American
T 99.7%
South Asian
T 99.9%
Admixed American (Latino)
C 1.4% · T 98.6%
Middle Eastern
C 0.7% · T 99.3%
Finnish
C 2.8% · T 97.2%
Ashkenazi Jewish
T 99.6%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C Two copies of the version the research linked to NAAA protein levels. That is the strongest link of the three results. A link in a study is not a diagnosis.
C/T One copy of the version the research linked to NAAA protein levels. That is a smaller link than two copies.
T/T No copy of the version the research linked to NAAA protein levels. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

NAAA protein levels (rs144228170). MyGeneLog™. https://www.mygenelog.com/variants/rs144228170

← See all variants